Cencora Inc
NYSE:COR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
211.7393
251.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Cencora Inc
Wall Street
Price Targets
COR Price Targets Summary
Cencora Inc
According to Wall Street analysts, the average 1-year price target for
COR
is 277.45 USD
with a low forecast of 239.37 USD and a high forecast of 317.1 USD.
COR Last Price Targets
Cencora Inc
The latest public price target was made on Sep 18, 2024 by
Daniel Grosslight
from
Citigroup
,
who expects
COR
stock to
rise by 19%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Daniel Grosslight
Citigroup
|
284
USD
Upside 19% |
3 months ago
Sep 18, 2024
|
Citi Reiterates Buy Rating on Cencora Inc (COR) Following Ransom Payment of $75M
StreetInsider
|
Allen Lutz
Bank of America Securities
|
245
USD
Upside 3% |
3 months ago
Sep 18, 2024
|
Cencora Inc (COR) PT Lowered to $245 at BofA Securities, Downgrade to Neutral
StreetInsider
|
David Rodgers
Robert W. Baird
|
283
USD
Upside 19% |
4 months ago
Sep 6, 2024
|
Cencora Inc (COR) PT Lowered to $283 at Baird
StreetInsider
|
|
David Rodgers
Robert W. Baird
|
287
USD
Upside 21% |
5 months ago
Aug 1, 2024
|
Cencora price target raised to $287 from $285 at Baird
TheFly
|
|
David Rodgers
Robert W. Baird
|
280
USD
Upside 18% |
7 months ago
May 29, 2024
|
Cencora Inc (COR) PT Raised to $280 at Baird
StreetInsider
|
|
David Rodgers
Robert W. Baird
|
275
USD
Upside 16% |
9 months ago
Apr 5, 2024
|
Cencora Inc (COR) PT Raised to $275 at Baird, 'expect continued strong execution'
StreetInsider
|
David Toung
Argus Research
|
270
USD
Upside 14% |
9 months ago
Apr 4, 2024
|
Cencora Inc (COR) PT Raised to $270 at Argus
StreetInsider
|
Ann Hynes
Mizuho Securities
|
174
USD
Downside 27% |
1 year ago
May 3, 2023
|
Healthcare Solutions Trends And M&A Prospects: AmerisourceBergen Gets A Price Target Hike Amid Upside Scenarios
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is COR's stock price target?
Price Target
277.45
USD
According to Wall Street analysts, the average 1-year price target for
COR
is 277.45 USD
with a low forecast of 239.37 USD and a high forecast of 317.1 USD.
What is Cencora Inc's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Cencora Inc's revenue is
9%.
The projected
CAGR
for the next 3 years is
7%.
What is Cencora Inc's Operating Income forecast?
Projected CAGR
13%
For the last 8 years the
compound annual growth rate for
Cencora Inc's operating income is
9%.
The projected
CAGR
for the next 3 years is
13%.
What is Cencora Inc's Net Income forecast?
Projected CAGR
32%
For the last 8 years the
compound annual growth rate for
Cencora Inc's net income is
1%.
The projected
CAGR
for the next 3 years is
32%.
You don't have any saved screeners yet
